A note on the coronavirus variant B.1.1.7, which has first been described in the U.K. and has spread to 57 countries. The note summarises…
Understanding why disagreement is good for COVID science. EMBL Deputy Director General Ewan Birney offers tips for sorting through the…
The story of a life-long friendship and a professional partnership that sowed the seeds for a ground-breaking vaccine…
December has seen the start of a new chapter in the collaboration that has for years marked the relationship between the European Commission (EC) and…
Bioinformaticians at EMBL-EBI and beyond are adapting computational tools to investigate coronavirus genomes and…
Researchers have studied SARS-CoV-2 replication in cells and obtained detailed insights into the alterations induced in infected cells. This…
By screening hundreds of sybodies (synthetic mini-antibodies), scientists have identified one that might stop SARS-CoV-2 from infecting human cells.…
Open access data benefits millions of scientists around the world and is essential for a rapid response to the COVID-19…
Scientists from the Beltrao Group at EMBL-EBI and collaborators identified drug targets common to SARS-CoV-2, SARS-CoV-1, and MERS-CoV, three…
More than 500 people have registered for an EMBL conference, "The impact of the COVID-19 crisis on women in science: Challenges and solutions."…
Europe PMC has begun indexing full-text COVID-19 preprints along with the associated data. The project aims to accelerate research to fight the…
The virtual EMBL Conference ‘SARS-CoV-2: Towards a New Era in Infection Research’ explored the importance of fundamental research, collaboration,…
Looking for past print editions of EMBLetc.? Browse our archive, going back 20 years.
EMBLetc. archive